Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Other Working Capital Changes (2016 - 2025)

Medifast (MED) has disclosed Other Working Capital Changes for 16 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 174.54% year-over-year to $1.9 million, compared with a TTM value of $2.1 million through Dec 2025, up 183.25%, and an annual FY2025 reading of $2.1 million, up 183.25% over the prior year.
  • Other Working Capital Changes was $1.9 million for Q4 2025 at Medifast, up from -$139000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $11.3 million in Q2 2022 and bottomed at -$10.1 million in Q3 2023.
  • Average Other Working Capital Changes over 5 years is $98700.0, with a median of $121000.0 recorded in 2021.
  • Peak annual rise in Other Working Capital Changes hit 2173.39% in 2022, while the deepest fall reached 1268.05% in 2022.
  • Year by year, Other Working Capital Changes stood at -$551000.0 in 2021, then skyrocketed by 1062.07% to $5.3 million in 2022, then tumbled by 55.08% to $2.4 million in 2023, then plummeted by 206.38% to -$2.5 million in 2024, then surged by 174.54% to $1.9 million in 2025.
  • Business Quant data shows Other Working Capital Changes for MED at $1.9 million in Q4 2025, -$139000.0 in Q3 2025, and $381000.0 in Q2 2025.